EndoChoice

EndoChoice

A platform-technology company that provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal diseases.

News

EndoChoice Selected as One of The Best and Brightest to Work For

EndoChoice has been named as one of “Atlanta’s Best and Brightest Companies to Work For™”, a designation that hundreds of companies pursue. EndoChoice was identified as a company that delivers exceptional human resource practices as measured by the National Association for Business Resources.

New Study Published in The Lancet Oncology Shows EndoChoice Fuse System Detects Significantly More Pre-Cancerous Polyps

Fuse™ Colonoscopy dramatically outperforms standard forward-viewing colonoscopes.

Healthcare CEO Roundtable Part I: Preparing for the Year Ahead

While healthcare reform is well underway, a true shift in care delivery and economics appears to be more of a looming threat than a proven reality. The question remains: How do you manage and grow a successful business in the dynamic environment of today while positioning for the future? We asked a few of the River Cities’ portfolio company CEOs some of the most prevalent questions on the minds of healthcare management teams when preparing for the year ahead.

Healthcare CEO Roundtable Part II: Healthcare Sales & Marketing in the Era of Reform

While healthcare reform is well underway, a true shift in care delivery and economics appears to be more of a looming threat than a proven reality. The question remains: How do you manage and grow a successful business in the dynamic environment of today while positioning for the future? We asked a few of the River Cities’ portfolio company CEOs some of the most prevalent questions on the minds of healthcare management teams when preparing for the year ahead.

EndoChoice Adds CEOs of UPS and Volcano Corporation to Board

Mr. Scott Davis, the Chairman and CEO of UPS (NYSE: UPS) and Mr. Scott Huennekens, President and CEO of Volcano Corporation (NASDAQ: VOLC) have joined the board as EndoChoice looks to more than double its revenue in 2014.

Page 1 of 3123

Status

Active

Fund

River Cities Fund IV

Year Invested

2008

City and State

Atlanta, GA

Testimonial

Portfolio Manager

Rik Vandevenne